Semler Scientific Inc. reported its financial results for the first quarter ended March 31, 2025. The company experienced a significant decline in revenues, reporting $8.8 million, which marks a 44% decrease compared to the same period last year. The cost of revenues was $0.9 million, reflecting a 25% year-over-year decrease. The company also reported a net loss of $64.7 million, or $6.74 per basic and diluted share, compared to a net income of $6.1 million for the first quarter of 2024. This change represents a notable downturn in the company's financial performance. Semler Scientific's income tax benefit for the quarter was $10.2 million, with an effective tax benefit rate of 14%, compared to an expense of $1.7 million, or an effective tax rate of 22%, in the first quarter of 2024. The company's two largest customers, including their affiliates, accounted for 42% and 32% of the revenues for the first quarter of 2025, respectively. In 2024, its three largest customers contributed 45%, 25%, and 11% to the first quarter revenues. In addition to the financial results, Semler Scientific announced that it will provide a business update on its near-term strategies during a conference call, with the information being accessible through its website dashboard.